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doi:10.1016/j.ejvs.2008.04.013Abstract Objectives: A new diagnostic imaging technique that can assess lymph function is
needed as a screening test in daily practice. This study assessed the use of indocyanine green
(ICG) fluorescence lymphography in subjects without leg oedema.
Methods: 0.3 ml of ICG (0.5 %) was injected subcutaneously at the dorsum of the foot. Subse-
quently, the movement of ICG dye from the injection site to the groin was traced by visualizing
its fluorescence signal with an infrared light camera. The time for the dye to reach the knee
and groin were measured (Transit time to knee: TTK, Transit time to groin: TTG). TTG was
measured while standing, lying at a supine position, standing with massage, and sitting while
using a cycle ergometer exercise at an intensity of 50 W at 50 rpm in ten healthy volunteers at
intervals of 14 days.
Results: Mean TTG during standing was 357 289 and 653 564 seconds for the right and left
legs respectively. Compared to TTG in the standing position, all other conditions shortened
TTG. In another seventeen subjects without leg oedema, we compared transit time obtained
with ICG fluorescence lymphography to that with dynamic lymphoscintigraphy. A significant
correlation between transit time measured with ICG lymphography and dynamic lymphoscinti-
graphy was identified (r2Z 0.64, p< 0.01).
Conclusions: ICG fluorescence lymphography has the potential to become an alternative
lymphatic imaging technique to assess lymph function.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.D, Division of Vascular Surgery, Second Department of Surgery Hamamatsu University School of
-ku Hamamatsu, Shizuoka 431-3192, Japan. Tel.: þ81 53 435 2279; fax: þ81 53 435 2273.
ac.jp (N. Unno).
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Lymph Function with Fluorescence Lymphography 231Introduction In this study, we describe ICG fluorescence lymphogra-Lymph flow imaging was reported first with direct lympho-
graphy using oil contrast agents1,2 and later with lympho-
scintigraphy using radioisotopes.3e5 Although direct
lymphography provides highly accurate and informative
images of lymph flow, the test is seldom performed at
present because it is a tedious procedure to expose foot
lymphatics and there is a risk of complications from the
contrast agent.6e8 Currently, lymphoscintigraphy is consid-
ered a major imaging modality for the diagnosis of patients
with lymphoedema and for evaluating lymphatic disorder in
the swollen extremity.9,10 Lymphoscintigraphy can detect
retarded tracer transport even in mild lymphoedema
without morphological abnormalities and is useful to evalu-
ate the functional lymph flow in patients with lymphatic
reconstruction.11 Quantitative analysis of lymph transport
is performed by obtaining dynamic images or measuring
the transit time for injected dye to reach the groin.12 How-
ever, lymphoscintigraphy is time consuming, expensive,
and potentially teratogenic during pregnancy, so that the
technique has only been performed on selected patients
in clinical practice.8
Recently, we introduced a new technique to observe
the lymph flow to visualize fluorescence of near-infrared
light of indocyanine green (ICG) as a tracer for the
diagnosis of lymphoedema.13 In that study, we reported
several characteristic images of fluorescence in patients
with secondary lymphoedema such as dermal back flow,
obstructed fluorescence images with dilatation, which
was compatible with the lymposcintigraphic findings.13
The technique is safe and minimally invasive. Further-
more, the technique allows real time video images to be
observed by tracing the ICG dye movement together with
patients on the monitor of a laptop computer. ICG has
been widely used in a variety of clinical situations such
as examination of hepatic function, and retinal angiogra-
phy with minor side effects.Figure 1 ICG fluorescence lymphography: real time Images of sup
vessel (B): ICG dye pushed forward to the proximal region in lymph p
the most advancing ICG dye in lymph vessel.phy as a new method for quantitatively assessing lymph
function.
Methods
Measurement of transit time in ICG
fluorescence lymphography
Ten healthy volunteers (all men) between the ages of 24
and 48 (mean 33.1 7.9 years) took part in this study, who
had no past history of cardiovascular disorders. Prior to
the study, duplex scanning was performed to confirm the
absence of venous insufficiency or deep vein thrombosis
(DVT) in the participants.
0.3 ml of indocyanine green (ICG: Diagnogreen 0.5%;
Daiichi Pharmatical, Tokyo, Japan) was subcutaneously
injected at the dorsum of the foot with a 27-gauge needle.
Immediately after the injection, fluorescence images of
subcutaneous lymphatic drainage were obtained using an
infrared camera system (PDE; Hamamatsu Photonics K.K.
Hamamatsu, Japan), which activates ICG with emitted light
(wavelength:760 nm) and filters out light with a wavelength
below 820 nm. The light source for emission of ICG consisted
of 760-nm LEDs, and the detector was a charge-coupled
device (CCD) camera. The fluorescence images were continu-
ously observed on the monitor of a laptop computer (LaVie G,
Type T; NEC Co., Tokyo, Japan). After injection of ICG at the
dorsum of the foot, fluorescent images of ICG dyewere traced
(Fig. 1), and the interval until the dye reached the groin was
measured (Transit time). The transit time was measured
under the following four conditions in each individual: stand-
ing, lying at a supine position, standing with massage, and
sitting while performing cycle ergometer exercise at an inten-
sity of 50 Wat 50 rpm. Because the fluorescence signals at the
dorsum of the foot remained for at least 7 days, repeated
measurements of transit time under each condition were
performed at intervals of at least 14 days.erficial lymph vessel (A): Fluorescence of ICG obtained in lymph
ropulsion (C): ICG dye further pushed forward. Arrows indicate
232 N. Unno et al.Comparison of transit time between dynamic
lymphoscintigraphy and ICG fluorescence
lymphography
Seventeen male patients (mean age 74.7 7.5 years) with
an abdominal aortic aneurysm who were hospitalized in
our surgical ward agreed to undergo an investigation of
their lymphatic function and underwent both lymphoscin-
tigraphy and ICG fluorescence lymphography before ab-
dominal aortic aneurysm (AAA) surgery. Duplex scanning
was also performed in these patients to exclude venous in-
sufficiency or deep vein thrombosis.
ICG fluorescence lymphography was also performed in
a supine position as described above. With real time
observation on the monitor of the laptop computer, both
Transit time (TT) from the dorsum to the knee (TTK) and TT
from the dorsum to the groin (TTG) were measured (Fig. 2).
On the next day, 0.3 ml of technetium 99m-labeled human
serum albumin diethylenetriamine pentaacetic acid (99mTc-
HSA-D, activity 111 MBq) (Nihon Medi-Physics Co., Ltd.,
Nishinomiya, Japan) was injected subcutaneously at the
dorsum of the foot at a distance of 1 cm from the site at
which ICG was previously injected. The subject remained
supine for imaging of the leg. Sequential images including
both the knee and inguinal regions were obtained every
30 seconds for a period of 20 minutes using a gammaFigure 2 Panoramic views of ICG fluorescence lymphography in
vessel. (A): Immediately after injection of ICG at the dorsum of fo
knee (TTK) was measured when ICG dye reached the knee (arrow). (
time to groin (TTG) was measured when ICG dye reached the groincamera, Dual-Head Variable-Geometry Nuclear Imaging
System (Millennium VG, GE Healthcare, Chalfont St Giles,
United Kingdom), and timeeactivity curves of the knee
and groin were created. The counts per second of each re-
gion were plotted against time. The times at which the
counts rose were defined as the lymphatic transit time to
the knee (TT K) and groin (TTG), respectively.
All data were expressed as mean standad deviation,
and the differences in the means between the groups
were assessed using paired one-sample Student’s t test. Re-
gression, correlation was calculated by GrapPad Prism
(ver.5, GraphPad Software, CA, USA).
Results
Transit time in ICG fluorescence lymphography
in different positions
Fluorescence images of continuous lymph channels running
along the medial aspect of the leg from the injection site to
the groin were traced with a handy camera probe. Lymph
propulsion was observed with pulsatile lymph flow images,
which suggested the pump function of lymphatic vessels
(Fig. 1). With ICG fluorescence lymphography, TTG at
a standing position was 357 289 and 653 564 seconds
for the right and left legs respectively. Among thea healthy volunteer: Sequential transition of ICG dye in lymph
ot. Arrow indicates the injection site. (B): Transit time to the
C): ICG dye was further propelled toward the groin. (D): Transit
(arrow).
Lymph Function with Fluorescence Lymphography 233participants, values differed ten-fold. The supine position
significantly shortened TTG on both sides compared to
that in standing position (157.3 107.7, 279.0 189.4
seconds, right leg (PZ 0.030), left leg (PZ 0.029), respec-
tively, (Fig. 3A). Standing with massage also significantly
shortened TTG bilaterally (53.9 16.2, 60.3 34.9 seconds,
right leg (PZ 0.009), left leg (PZ 0.007), respectively,
(Fig. 3B). Moreover, TTG in a sitting position while exercise
using bicycle ergometer also seemed to be shorter than
that in a standing position (183.4 93.2, 237.3 177.2
seconds, right leg (PZ 0.094), left leg (PZ 0.047),
respectively, (Fig. 3C).
Comparison of transit time between dynamic
lymphoscintigraphy and ICG fluorescence
lymphography
In 17 subjects, both dynamic lymphography and ICG fluores-
cence lymphography were performed with an interval of 24
hours to measure both TTK and TTG in each individual. WithFigure 3 Transit time to groin (TTG) in ICG fluorescence lymphog
were plotted for each leg in each condition. The mean ( S.D.) of T
Standing position vs standing with manual massage (C) Standing poICG fluorescence lymphography, TTK and TTG in a supine
position in 17 subjects were 203.6 166.9 and 329.6
311.5 seconds, respectively. With dynamic lymphoscintigra-
phy, TTK and TTG were measured from the time-activity
curves (Fig. 4B.C). Gamma camera showed the sequence
of the 99mTc- HSA-D movement from the dorsum of the
foot to the groin via the knee (Fig. 4A). TTK and TTG in
a supine position were 264.7 276.3 and 481.8 407.1
seconds, respectively. There was a strong correlation
between transit time measured with ICG lymphography and
dynamic lymphoscintigraphy (Fig. 5).
Discussion
We previously reported the usefulness of fluorescence ICG
lymphography to facilitate diagnosis of secondary lymphoe-
dema and described the morphological characteristics of
fluorescence lymph imaging. ICG lymphography clearly
visualized the dilated, tortuous lymph vessels with proximal
obstruction as well as dermal backflow. ICG absorbs light inraphy in different positions. Data from individual participants
TG was also shown. (A) Standing position vs supine position (B)
sition vs sitting with exercise using ergometer.
Figure 4 (A) Dynamic lymphoscintigraph of the lower limb. Circle and arrows indicate the site of knee and groin where the time-
activity curves were created. Solid arrow: right side. dashed arrow: left side. (B) Bilateral time-activity curves at knee. Arrows
indicate the transit time to knee (TTK) (C) Bilateral time-activity curves at groin. Arrows indicate the transit time to groin (TTG).
Figure 5 Linear regression analysis shows a comparison of
transit time measured by dynamic lymphoscintigraphy vs ICG
fluorescence lymphography.
234 N. Unno et al.the near-infrared range, with a maximum at 805 nm. The
excitation wavelength of ICG that produces the maximum
fluorescence is 765 nm. ICG fluorescences with a maximum
at 840 nm in plasma.14 The fluorescence of ICG in the near
infrared wavelength can deeply penetrate living tissue and
is advantageous for obtaining visual information. The great-
est advantages of this imaging technique include its ease
and real time visualization as well as safety. Recently,
Ogata et al. applied the technique intraoperatively to assist
lymphaticovenular anastomoses for patients with lymphoe-
dema.15 In this study, we also took advantage of the real-
time visualization of ICG lymphography and succeeded in
measuring transit time (i.e. interval until appearance at
the region of interest) in subjects without leg oedema.
Because the infrared camera clearly visualized lymph
propelled toward the proximal region, it was easy to
measure the time from the injection site to the region of
interest, although the camera limits the detection of
lymphatic vessels located less than 2 cm from the body
surface so that the detection of deep lymph vessels, which
run in the subfascial space, may be difficult with this
system, particularly, in a fat subject or a fat-rich region.
In this study, pulsatile lymph flow was identified in a fluores-
cent vessel in a supine position, which was compatible with
the notion proposed by Smith et al. that spontaneous con-
tractions are an important means by which lymph is
propelled.16 Sharma et al. measured lymph velocities as
0.23e0.75 cm/s by determining the transit time of ICG
fluorescence signal traversing 2e16 cm length of surface
lymph vessels in swine.17 In this study, the transit time in
a supine position was shorter than that in a standing
position. Like the venous system, the standing position
creates hydrostatic pressure so that the lymph trunk must
propel lymph against gravity. With massage or exerciseusing an ergometer, the transit time was also shortened,
indicating that muscle contraction could accelerate lymph
flow and/or pump pressure. Many other studies have
confirmed the role of muscular contraction or limb exercise
in promoting lymph flow, which is similar to leg venous flow
propelled by a ‘‘muscle pump’’.18,19 However, our study
scale was too small and further study is needed to confirm
the results. In this study, the ethical committee in our insti-
tute did not approve the performance of radioisotope
scintigram in healthy volunteers who are relatively young.
Therefore, we performed the comparison of transit times
between ICG lymphography and dynamic lymphoscintigra-
phy in preoperative AAA patients without venous diseases
who comprised a relatively older population. Because the
Lymph Function with Fluorescence Lymphography 235preoperative patients were hospitalized in our surgical
ward under similar conditions, uniform injection of both
ICG and radioisotope was performed at exactly the same
time within a 24-hour interval. There was a significant
correlation in transit time between both tracers. However,
there is a possibility that subcutaneous injection with
a 1 cm distance and 24-hour interval may affect tracer
uptake and change the transit time due to local inflamma-
tory response. Therefore, simultaneous injection of both
ICG and radioisotope might result in even better correlation
between the tracers’ transit times.
The transit time, measured in relation to the tracer
distance, was introduced in dynamic scintigraph.20,21 The
transport capacity of lymph is determined not by the speed
of lymph flow but by the volume over time, transit time is
definitely not the sole parameter of lymph function.
Nonetheless, many previous studies measured transit time
as one of parameters to assess lymph function, or at least
included transit time among the categories of evaluating
lymph function.12,22 Previous reports23,24 identified that
the measurement of transit time, and combination of
qualitative and quantitative assessment with lymphoscin-
tigraphy, enhance the diagnostic sensitivity for detecting
lymphoedema particularly for patients with mild or incipi-
ent symptoms. Ohtake et al. reported that transit time to
the groin ranged between 2 and 6 minutes, and Mandel
et al. reported the time to be around 10 minutes in healthy
subjects without leg oedema.20,25 In our study, TTG in
a supine position was between 2 and 5 minutes with ICG
lymphography and between 3 and 5 minutes with dynamic
lymphoscintigraphy, which was similar to the values
reported in previous studies. These results, together with
the significant correlations between transit time measured
with ICG lymphography and dynamic lymphoscintigraphy,
suggest ICG lymphography may become an alternative
method of assessing lymph function. Currently, none of
the quantitative lymphoscintigraphy has been standardized
for application in daily practice because many hospitals use
various radioisotopes at different radioactivity doses under
different protocols of image interpretation. Either intrader-
mal or subcutaneous injection also affects the results.24,26
Consequently, quantitative lymphoscintigraphy have been
performed only for selected patients with swollen extrem-
ities in a limited number of hospitals, where not only an
expensive gamma camera system is available but also
a well-trained technician together with radiologists. As
described above, our technique is reliable only for the
study of superficial lymphatics (< 2 cm to the skin). There-
fore, the importance of deep lymphatic chains cannot be
assessed with this method. However, in healthy individuals
or lymphoedema patients with incipient symptoms, the
superficial lymphatics are maintained and may play
a greater role in lymph drainage than deep lymphatic
chains. Our method may detect the early stages of malfunc-
tion of superficial lymphatics before irreversible damage is
identified as morphological changes on lymphography.
In this study, we performed ICG fluorescence lymphog-
raphy and measured transit time only for subjects with
normal legs. Although the results were encouraging as
a new diagnostic method to assess lymph function, further
study is needed to apply those technique to patients with
swollen extremities to identify differences from imagesobtained from healthy volunteers. Moreover, other causes
of leg oedema such as venous insufficiency, cirrhosis, and
malnutrition should also be evaluated with this method to
determine whether these causes affect the lymph function
or not. With application of quantitative analysis of lymph
function together with qualitative assessment to such
patients with leg oedema, we may detect lymphatic
disorder concurrent with other diseases.
In conclusion, ICG fluorescence lymphography is safe and
minimally invasive, and can be performed repeatedly.
Measurement of the transit time for lymph flow to the
region of interest using this technique may facilitate the
assessment of lymph function in patients with swollen legs.
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